Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

This study has been completed.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Soad Bekheit, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT01590979
First received: April 27, 2012
Last updated: August 18, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)